Patents by Inventor Marty Bernardus Fransiscus Wulferink

Marty Bernardus Fransiscus Wulferink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Modified Phosphatases
    Publication number: 20160046913
    Abstract: The invention relates to phosphatases and more in specific to (genetically) modified phosphatases, pharmaceutical compositions comprising (genetically) modified phosphatases and the use of (genetically) modified phosphatases for treating or curing for example sepsis, inflammatory bowel disease or other inflammatory diseases, or renal failure. The invention further relates to a method for producing phosphatases.
    Type: Application
    Filed: March 23, 2015
    Publication date: February 18, 2016
    Applicant: AM-PHARMA B.V.
    Inventors: Markwin Paul VELDERS, Luigi Johannes Cornelius JONK, Willem RAABEN, Marty Bernardus Fransiscus WULFERINK
  • Modified Phosphatases
    Publication number: 20140193388
    Abstract: The invention relates to phosphatases and more in specific to (genetically) modified phosphatases, pharmaceutical compositions comprising (genetically) modified phosphatases and the use of (genetically) modified phosphatases for treating or curing for example sepsis, inflammatory bowel disease or other inflammatory diseases, or renal failure. The invention further relates to a method for producing phosphatases.
    Type: Application
    Filed: September 6, 2013
    Publication date: July 10, 2014
    Applicant: AM-PHARMA B.V.
    Inventors: MARKWIN PAUL VELDERS, LUIGI JOHANNES CORNELIUS JONK, WILLEM RAABEN, MARTY BERNARDUS FRANSISCUS WULFERINK
  • Modified phosphatases
    Patent number: 8557545
    Abstract: The invention relates to phosphatases and more in specific to (genetically) modified phosphatases, pharmaceutical compositions comprising (genetically) modified phosphatases and the use of (genetically) modified phosphatases for treating or curing for example sepsis, inflammatory bowel disease or other inflammatory diseases, or renal failure. The invention further relates to a method for producing phosphatases.
    Type: Grant
    Filed: April 25, 2008
    Date of Patent: October 15, 2013
    Assignee: Am-Pharma B.V.
    Inventors: Markwin Paul Velders, Luigi Johannes Cornelius Jonk, Willem Raaben, Marty Bernardus Fransiscus Wulferink
  • MODIFIED PHOSPHATASES
    Publication number: 20100143323
    Abstract: The invention relates to phosphatases and more in specific to (genetically) modified phosphatases, pharmaceutical compositions comprising (genetically) modified phosphatases and the use of (genetically) modified phosphatases for treating or curing for example sepsis, inflammatory bowel disease or other inflammatory diseases, or renal failure. The invention further relates to a method for producing phosphatases.
    Type: Application
    Filed: April 25, 2008
    Publication date: June 10, 2010
    Inventors: Markwin Paul Velders, Luigi Johannes Cornelius Jonk, Willem Raaben, Marty Bernardus Fransiscus Wulferink
  • Mutants of lactoferrin
    Publication number: 20090069244
    Abstract: The invention relates to field of biochemistry, molecular biology as well as medicinal chemistry. More in specific, the invention relates to polypeptides derived from human lactoferrin and their use in therapeutic or prophylactic treatment. The invention provides a polypeptide comprising a mutant of the amino acid sequence RRRRSVQWC (SEQ ID NO:2), which mutation comprising polypeptide has comparable antimicrobial activity against at least one micro-organism if compared to a reference polypeptide comprising the amino acid sequence RRRRSVQWC (SEQ ID NO:2).
    Type: Application
    Filed: August 27, 2008
    Publication date: March 12, 2009
    Applicant: AM-Pharma B.V.
    Inventors: Cornelis Peter Johannes Maria Brouwer, Luigi Johannes Cornelius Jonk, Markwin Paul Velders, Marty Bernardus Fransiscus Wulferink